1,497
Views
6
CrossRef citations to date
0
Altmetric
Review

A comprehensive review of protein kinase inhibitors for cancer therapy

&
Pages 1249-1270 | Received 15 Jun 2018, Accepted 20 Sep 2018, Published online: 09 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Bettina Wedi. (2023) Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development. Expert Opinion on Investigational Drugs 32:11, pages 1043-1054.
Read now
Nilofer Shaikh, R. K Linthoi, K. V. Swamy, Muthukumarasamy Karthikeyan & Renu Vyas. (2023) Comprehensive molecular docking and dynamic simulations for drug repurposing of clinical drugs against multiple cancer kinase targets. Journal of Biomolecular Structure and Dynamics 41:16, pages 7735-7743.
Read now
Srimathi Kurma, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela, Vinitha Badithapuram, Gouthami Dasari & Srinivas Bandari. (2023) Design and Synthesis of Some New Quinoxaline-1,2,4-Oxadiazole-Amide Conjugates as EGFR Targeting Agents and ADMET Studies. Polycyclic Aromatic Compounds 0:0, pages 1-14.
Read now
N. Abd Emoniem, R.M. Mukhtar, H. Ghaboosh, E.M. Elshamly, M.A. Mohamed, T. Elsaman & A.A. Alzain. (2023) Turning down PI3K/AKT/mTOR signalling pathway by natural products: an in silico multi-target approach. SAR and QSAR in Environmental Research 34:2, pages 163-182.
Read now
Vishal Unadkat, Shishir Rohit, Paranjay Parikh, Kaushal Patel, Vinod Sanna & Sanjay Singh. (2022) Identification of 1,2,4-Oxadiazoles-Based Novel EGFR Inhibitors: Molecular Dynamics Simulation-Guided Identification and in vitro ADME Studies. OncoTargets and Therapy 15, pages 479-495.
Read now
Mohamed A Abdelgawad, Arafa Musa, Atiah H Almalki, Sami I Alzarea, Ehab M Mostafa, Mostafa M Hegazy, Gomaa Mostafa-Hedeab, Mohammed M Ghoneim, Della G T Parambi, Rania B Bakr, Nayef S Al-Muaikel, Abdullah S Alanazi, Metab Alharbi, Waqas Ahmad, Syed N A Bukhari & Mohammad M Al-Sanea. (2021) Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights. Drug Design, Development and Therapy 15, pages 2325-2337.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.